free     free     free  :  Publisher  :   free English Wikipedia <ref>{{Cite pmid|19672244}}</ref> Nephropedia Template TP ( {{tp|p=19672244|t=Targeting cancer-initiating cells with oncolytic viruses |pdf=|usr=|}} Twit Text Targeting cancer-initiating cells with oncolytic viruses http://www.kidney.de/pget.php?&tw=1&pmid=19672244 DeepDyve Pubget Overpricing

lüll Targeting cancer-initiating cells with oncolytic viruses Cripe TP; Wang PY; Marcato P; Mahller YY; Lee PW Mol Ther 2009[Oct]; 17 (10): 1677-82 Recent studies in a variety of leukemias and solid tumors indicate that there is significant heterogeneity with respect to tumor-forming ability within a given population of tumor cells, suggesting that only a subpopulation of cells is responsible for tumorigenesis. These cells have been commonly referred to as cancer stem cells (CSCs) or cancer-initiating cells (CICs). CICs have been shown to be relatively resistant to conventional anticancer therapies and are thus thought to be responsible for disease relapse. As such, they represent a potentially critical therapeutic target. Oncolytic viruses are in clinical trials for cancer and kill cells through mechanisms different from conventional therapeutics. Because these viruses are not susceptible to the same pathways of drug or radiation resistance, it is important to learn whether CICs are susceptible to oncolytic virus infection. Here we review the available data regarding the ability of several different oncolytic virus types to target CICs for destruction. |Animals[MESH] |Humans[MESH] |Neoplastic Stem Cells/*virology[MESH] |Oncolytic Virotherapy/*methods[MESH] |Oncolytic Viruses/genetics/physiology[MESH]

*{{pmid19672244}}
*<b>[http://www.kidney.de/mlpefetch.php?search=19672244 Targeting cancer-initiating cells with oncolytic viruses ]</b> Mol Ther 2009; 17(10) ; 1677-82 Cripe TP; Wang PY; Marcato P; Mahller YY; Lee PW

    *19672244*

Nephropedia PMID record
{{recpmid|pmid=19672244|ti=Targeting cancer-initiating cells with oncolytic viruses |au=Cripe TP; Wang PY; Marcato P; Mahller YY; Lee PW|so=Mol Ther 2009; 17 (10): 1677-82|ab=Recent studies in a variety of leukemias and solid tumors indicate that there is significant heterogeneity with respect to tumor-forming ability within a given population of tumor cells, suggesting that only a subpopulation of cells is responsible for tumorigenesis. These cells have been commonly referred to as cancer stem cells (CSCs) or cancer-initiating cells (CICs). CICs have been shown to be relatively resistant to conventional anticancer therapies and are thus thought to be responsible for disease relapse. As such, they represent a potentially critical therapeutic target. Oncolytic viruses are in clinical trials for cancer and kill cells through mechanisms different from conventional therapeutics. Because these viruses are not susceptible to the same pathways of drug or radiation resistance, it is important to learn whether CICs are susceptible to oncolytic virus infection. Here we review the available data regarding the ability of several different oncolytic virus types to target CICs for destruction.}}
Deutsche Wikipedia - im Artikel
<ref>{{BibPMID|19672244}}</ref>
Hier den unten stehenden Textblock hineinkopieren
{{BibRecord | Autor = Cripe TP; Wang PY; Marcato P; Mahller YY; Lee PW | Titel = Targeting cancer-initiating cells with oncolytic viruses | Band = 17 | Nummer = 10 | Jahr = 2009 | Monat = Oct | Sprache = eng | DOI = | Seite = 1677-82 | PMID = 19672244 | Typ= {{{Typ|}}} | Kommentar = {{{Kommentar|}}} | format = {{{format|}}} | record = {{{record|}}} }}

Mol Ther